長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4569】杏林製薬

【4569】杏林製薬
製薬。ぜんそく薬、去痰剤。ジェネリックも。
類似企業：
【業界1位】 小野薬品工業
【売上同水準】 久光製薬 持田製薬


東証プライム
医薬
＞
医他
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2025.03 2024/11/07 Q2予 123,400 → 0.0% 0.0% 6,500 → 0.0% 0.0% 6,900 → 0.0% 0.0% 5,000 → 0.0% 0.0%
2025.03 2024/07/31 Q1予 123,400 → 0.0% 0.0% 6,500 → 0.0% 0.0% 6,900 → 0.0% 0.0% 5,000 → 0.0% 0.0%
2025.03 2024/05/10 当初予 123,400 - - - 6,500 - - - 6,900 - - - 5,000 - - -
2024.03 2024/05/10 実 119,532 ↑ +2.9% +2.9% 6,013 ↑ +0.2% +0.2% 6,602 ↑ +1.6% +1.6% 5,322 ↑ +8.6% +8.6%
2024.03 2024/02/06 Q3予 116,200 → 0.0% 0.0% 6,000 → 0.0% 0.0% 6,500 → 0.0% 0.0% 4,900 → 0.0% 0.0%
2024.03 2023/11/08 Q2予 116,200 → 0.0% 0.0% 6,000 → 0.0% 0.0% 6,500 → 0.0% 0.0% 4,900 → 0.0% 0.0%
2024.03 2023/08/02 Q1予 116,200 → 0.0% 0.0% 6,000 → 0.0% 0.0% 6,500 → 0.0% 0.0% 4,900 → 0.0% 0.0%
2024.03 2023/05/11 当初予 116,200 - - - 6,000 - - - 6,500 - - - 4,900 - - -
2023.03 2023/05/11 実 113,270 ↑ +1.1% +1.1% 5,123 ↓ -6.9% -6.9% 5,827 ↓ -2.9% -2.9% 4,723 ↑ +5.0% +5.0%
2023.03 2023/02/06 Q3予 112,000 → 0.0% 0.0% 5,500 → 0.0% 0.0% 6,000 → 0.0% 0.0% 4,500 → 0.0% 0.0%
2023.03 2022/11/09 Q2予 112,000 → 0.0% 0.0% 5,500 → 0.0% 0.0% 6,000 → 0.0% 0.0% 4,500 → 0.0% 0.0%
2023.03 2022/08/02 Q1予 112,000 → 0.0% 0.0% 5,500 → 0.0% 0.0% 6,000 → 0.0% 0.0% 4,500 → 0.0% 0.0%
2023.03 2022/05/11 当初予 112,000 - - - 5,500 - - - 6,000 - - - 4,500 - - -
2022.03 2022/05/11 実 105,534 ↑ +0.0% +2.9% 5,007 ↑ +0.1% +51.7% 5,569 ↑ +1.3% +46.6% 3,932 ↑ +3.5% +45.6%
2022.03 2022/04/26 修正予 105,500 ↑ +2.8% +2.8% 5,000 ↑ +51.5% +51.5% 5,500 ↑ +44.7% +44.7% 3,800 ↑ +40.7% +40.7%
2022.03 2022/02/04 Q3予 102,600 → 0.0% 0.0% 3,300 → 0.0% 0.0% 3,800 → 0.0% 0.0% 2,700 → 0.0% 0.0%
2022.03 2021/11/08 Q2予 102,600 → 0.0% 0.0% 3,300 → 0.0% 0.0% 3,800 → 0.0% 0.0% 2,700 → 0.0% 0.0%
2022.03 2021/08/03 Q1予 102,600 → 0.0% 0.0% 3,300 → 0.0% 0.0% 3,800 → 0.0% 0.0% 2,700 → 0.0% 0.0%
2022.03 2021/05/11 当初予 102,600 - - - 3,300 - - - 3,800 - - - 2,700 - - -
2021.03 2021/05/11 実 102,904 ↑ +0.0% -10.9% 5,786 ↑ +1.5% -40.4% 6,447 ↑ +0.7% -36.8% 6,130 ↑ +0.5% -19.3%
2021.03 2021/05/07 修正予 102,900 ↓ -4.7% -10.9% 5,700 ↓ -26.9% -41.2% 6,400 ↓ -23.8% -37.3% 6,100 ↓ -15.3% -19.7%
2021.03 2021/02/04 Q3予 108,000 ↑ +900.0% -6.5% 7,800 → 0.0% -19.6% 8,400 → 0.0% -17.6% 7,200 → 0.0% -5.3%
2021.03 2020/11/05 修正予 10,800 ↓ -90.6% -90.6% 7,800 ↓ -19.6% -19.6% 8,400 ↓ -17.6% -17.6% 7,200 ↓ -5.3% -5.3%
2021.03 2020/08/03 Q1予 115,500 → 0.0% 0.0% 9,700 → 0.0% 0.0% 10,200 → 0.0% 0.0% 7,600 → 0.0% 0.0%
2021.03 2020/05/12 当初予 115,500 - - - 9,700 - - - 10,200 - - - 7,600 - - -
2020.03 2020/05/12 実 109,983 ↑ +0.5% -3.6% 7,503 ↑ +15.4% -17.5% 8,175 ↑ +15.1% -14.8% 6,149 ↑ +13.9% -13.4%
2020.03 2020/02/05 Q3予 109,400 → 0.0% -4.1% 6,500 → 0.0% -28.6% 7,100 → 0.0% -26.0% 5,400 → 0.0% -23.9%
2020.03 2019/11/07 修正予 109,400 ↓ -4.1% -4.1% 6,500 ↓ -28.6% -28.6% 7,100 ↓ -26.0% -26.0% 5,400 ↓ -23.9% -23.9%
2020.03 2019/07/31 Q1予 114,100 → 0.0% 0.0% 9,100 → 0.0% 0.0% 9,600 → 0.0% 0.0% 7,100 → 0.0% 0.0%
2020.03 2019/05/13 当初予 114,100 - - - 9,100 - - - 9,600 - - - 7,100 - - -
2019.03 2019/05/13 実 113,620 ↑ +2.7% -0.7% 8,972 ↑ +9.4% +4.3% 9,438 ↑ +9.7% +2.6% 6,869 ↑ +12.6% +4.1%
2019.03 2019/02/05 Q3予 110,600 ↓ -3.3% -3.3% 8,200 ↓ -4.7% -4.7% 8,600 ↓ -6.5% -6.5% 6,100 ↓ -7.6% -7.6%
2019.03 2018/11/05 Q2予 114,400 → 0.0% 0.0% 8,600 → 0.0% 0.0% 9,200 → 0.0% 0.0% 6,600 → 0.0% 0.0%
2019.03 2018/07/31 Q1予 114,400 → 0.0% 0.0% 8,600 - - - 9,200 → 0.0% 0.0% 6,600 → 0.0% 0.0%
2019.03 2018/05/10 当初予 114,400 - - - - - - - 9,200 - - - 6,600 - - -
2018.03 2018/05/10 実 - - - - - - - - - - - - - - - -
2018.03 2018/02/05 Q3予 111,300 → 0.0% -1.9% 10,500 → 0.0% -13.2% 10,900 → 0.0% -13.5% 7,800 → 0.0% -19.6%
2018.03 2017/11/06 Q2予 111,300 ↓ -1.9% -1.9% 10,500 ↓ -13.2% -13.2% 10,900 ↓ -13.5% -13.5% 7,800 ↓ -19.6% -19.6%
2018.03 2017/07/31 Q1予 113,400 → 0.0% 0.0% 12,100 → 0.0% 0.0% 12,600 → 0.0% 0.0% 9,700 → 0.0% 0.0%
2018.03 2017/05/11 当初予 113,400 - - - 12,100 - - - 12,600 - - - 9,700 - - -
2017.03 2017/05/11 実 115,373 ↑ +0.3% -3.9% 10,413 ↑ +4.1% -28.2% 10,874 ↑ +4.6% -27.0% 7,305 ↑ +10.7% -31.7%
2017.03 2017/02/03 Q3予 115,000 ↓ -4.2% -4.2% 10,000 ↓ -31.0% -31.0% 10,400 ↓ -30.2% -30.2% 6,600 ↓ -38.3% -38.3%
2017.03 2016/11/07 Q2予 120,000 → 0.0% 0.0% 14,500 → 0.0% 0.0% 14,900 → 0.0% 0.0% 10,700 → 0.0% 0.0%
2017.03 2016/07/29 Q1予 120,000 → 0.0% 0.0% 14,500 → 0.0% 0.0% 14,900 → 0.0% 0.0% 10,700 → 0.0% 0.0%
2017.03 2016/05/12 当初予 120,000 - - - 14,500 - - - 14,900 - - - 10,700 - - -
2016.03 2016/05/12 実 119,483 ↓ -0.6% -0.6% 19,636 ↑ +1.2% +22.7% 19,995 ↑ +1.5% +22.7% 13,639 ↑ +4.9% +18.6%
2016.03 2016/02/03 修正予 120,200 → 0.0% 0.0% 19,400 ↑ +21.2% +21.2% 19,700 ↑ +20.9% +20.9% 13,000 ↑ +13.0% +13.0%
2016.03 2015/11/05 Q2予 120,200 → 0.0% 0.0% 16,000 → 0.0% 0.0% 16,300 → 0.0% 0.0% 11,500 → 0.0% 0.0%
2016.03 2015/07/30 Q1予 120,200 → 0.0% 0.0% 16,000 → 0.0% 0.0% 16,300 → 0.0% 0.0% 11,500 → 0.0% 0.0%
2016.03 2015/05/13 当初予 120,200 - - - 16,000 - - - 16,300 - - - 11,500 - - -
2015.03 2015/05/13 実 113,121 ↑ +1.3% +0.8% 14,737 ↑ +6.8% -6.7% 15,490 ↑ +8.3% -5.0% 12,064 ↑ +4.0% +6.8%
2015.03 2015/02/02 Q3予 111,700 → 0.0% -0.4% 13,800 → 0.0% -12.7% 14,300 → 0.0% -12.3% 11,600 → 0.0% +2.7%
2015.03 2014/11/04 Q2予 111,700 ↓ -0.4% -0.4% 13,800 ↓ -12.7% -12.7% 14,300 ↓ -12.3% -12.3% 11,600 ↑ +2.7% +2.7%
2015.03 2014/07/29 Q1予 112,200 → 0.0% 0.0% 15,800 → 0.0% 0.0% 16,300 → 0.0% 0.0% 11,300 → 0.0% 0.0%
2015.03 2014/05/09 当初予 112,200 - - - 15,800 - - - 16,300 - - - 11,300 - - -
2014.03 2014/05/09 実 111,400 - - - 17,607 - - - 18,281 - - - 12,025 - - -
シェア ツイート
ページトップへ戻る